← Back to Search

Brain Stimulation

Brain Stimulation for Depression

N/A
Recruiting
Led By Jon Willie, MD
Research Sponsored by Inner Cosmos Inc
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Study Summary

This trial is testing a new method of treatment for severely depressed patients who have not responded to other treatments. A small electrode will be placed in the skull and intermittently activated to modulate brain regions. The goal is to decrease depression symptoms. Up to 20 subjects will be enrolled and followed for up to one year.

Who is the study for?
This trial is for adults aged 21-80 with severe depression that hasn't improved after trying at least two different types of antidepressants. They must have had some response to non-invasive neurostimulation, not be pregnant or able to become pregnant, and be capable of undergoing brain scans and cognitive tests.Check my eligibility
What is being tested?
The study is testing a minimally invasive brain stimulation technique called IpCS on the prefrontal cortex in patients with treatment-resistant depression. Up to 20 participants will receive an electrode implant and their mood will be monitored over a year using the MADRS scale.See study design
What are the potential side effects?
Potential side effects may include discomfort from the surgical procedure, risk of infection, possible changes in cognition or mood due to stimulation, and any unforeseen reactions related to having an implanted device.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in depression symptoms
Secondary outcome measures
Change in cognitive function

Trial Design

1Treatment groups
Experimental Treatment
Group I: Intervention, Placement of Device & StimulationExperimental Treatment1 Intervention
Placement of neurostimulation device & stimulation of prefrontal cortex target

Find a Location

Who is running the clinical trial?

Inner Cosmos IncLead Sponsor
Washington University School of MedicineOTHER
1,937 Previous Clinical Trials
2,299,735 Total Patients Enrolled
68 Trials studying Depression
23,359 Patients Enrolled for Depression
Jon Willie, MDPrincipal InvestigatorWashington University School of Medicine

Media Library

INTRACALVARIAL PREFRONTAL CORTICAL STIMULATION (IpCS) (Brain Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05393622 — N/A
Depression Research Study Groups: Intervention, Placement of Device & Stimulation
Depression Clinical Trial 2023: INTRACALVARIAL PREFRONTAL CORTICAL STIMULATION (IpCS) Highlights & Side Effects. Trial Name: NCT05393622 — N/A
INTRACALVARIAL PREFRONTAL CORTICAL STIMULATION (IpCS) (Brain Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05393622 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I qualified to take part in this research endeavor?

"This trial aims to enroll 20 individuals suffering from depression and aged between 21 and 80. They must satisfy the following conditions: Written consent for participation, diagnosis of chronic/recurrent depression with a MADRS score >/=20, no sustained response to two or more antidepressant treatments classes in their current depressive episode, completion of all baseline tests prior to implant surgery (including CT & MRI brain scans), women not pregnant nor capable of becoming pregnant; age range is 21-80 years old; able to complete evaluation including high resolution CT & MRI imaging."

Answered by AI

Is this research endeavor welcoming persons aged 45 or above as participants?

"This clinical trial dictates that participants must be between 21 and 80 years old. In contrast, there are 193 trials recruiting those under 18 while 967 studies focus on patients above the age of 65."

Answered by AI

Are there any openings for prospective patients to join this clinical exploration?

"Data hosted on clinicaltrials.gov shows that this trial is no longer recruiting for new participants, with the original post dating back to June 1st 2022 and last updated on May 23rd 2022. Nevertheless, there are over 1296 other trials currently open for patient recruitment at present."

Answered by AI
~9 spots leftby Dec 2025